ReviewLife (Basel, Switzerland)2022
Quality of Multicenter Studies Using MRI Radiomics for Diagnosing Clinically Significant Prostate Cancer: A Systematic Review.
Review in Life (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Apparent diffusion coefficient radiomics for differentiating benign and malignant PI-RADS 3-5 prostate lesions: external validation.International urology and nephrology · 2026Article
- Adherence to the Checklist for Artificial Intelligence in Medical Imaging (CLAIM): an umbrella review with a comprehensive two-level analysis.Diagnostic and interventional radiology (Ankara, Turkey) · 2025Article
- Prostate cancer MRI methodological radiomics score: a EuSoMII radiomics auditing group initiative.European radiology · 2025Review
- Robust radiomics: a review of guidelines for radiomics in medical imaging.Frontiers in radiology · 2025Review
- Development of a Secure Web-Based Medical Imaging Analysis Platform: The AWESOMME Project.Journal of imaging informatics in medicine · 2024Article
- Emerging Trends in AI and Radiomics for Bladder, Kidney, and Prostate Cancer: A Critical Review.Cancers · 2024Review
- The impact of pre-processing and disease characteristics on reproducibility of T2-weighted MRI radiomics features.Magma (New York, N.Y.) · 2023Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.